Status:
COMPLETED
Prediction of the Response to Neoadjuvant Radiation Chemotherapy Through Texture Analysis Derived From Medical Imaging
Lead Sponsor:
University Hospital, Brest
Conditions:
Rectal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
In patient with complete pathological response, surgery could be omitted without compromising progression-free or overall survival. A powerful prediction model is needed to guide management of this po...
Eligibility Criteria
Inclusion
- locally advanced rectal cancer
- patients who received concomitant radio-chemotherapy followed by surgery
- pre-therapeutic MRI and CT-scan dicom available
Exclusion
- age under 18 yo
- lack of MRI or CT-scan
Key Trial Info
Start Date :
January 2 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
124 Patients enrolled
Trial Details
Trial ID
NCT04920435
Start Date
January 2 2019
End Date
December 31 2019
Last Update
December 7 2021
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier de Cornouaille
Quimper, Brittany Region, France, 29000
2
ICO
Nantes, Saint Herblain, France, 44800
3
CHRU de Brest (Morvan)
Brest, France